FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
FDA General

Sharp Reductions in FDA Operations Under Shutdown: HHS

An HHS contingency plan says FDA would experience sharp reductions in operations if Congress fails to reach a deal to fund the government.

latest-news-card-1
Medical Devices

FDA Approves New Zoll Monitor/Defibrillator

FDA approves a Zoll Medical PMA for Zenix, the companys newest monitor/defibrillator, which the company says is designed to streamline emergency and h...

latest-news-card-1
Human Drugs

OND Custom Medical Queries Are Useful: Article

FDA researchers say the OND Custom Medical Queries developed to improve the identification and analysis of new drug safety signals have improved FDAs ...

latest-news-card-1
Human Drugs

New Guidance on Adaptive Clinical Trial Designs

FDA posts an International Council for Harmonization draft guideline entitled E20 Adaptive Designs for Clinical Trials that provides recommendations o...

latest-news-card-1
Medical Devices

CDRH Expands Recall of BD Alaris Pump Infusion Sets

FDA issues an updated alert about an ongoing Class 1 recall of certain BD Alaris Pump Module infusion sets due to device performance issues.

FDA General

FDA Protected From Firings During Shutdown: Makary

FDA commissioner Marty Makary tells agency employees that they are protected from planned mass workforce firings if a government shutdown goes into ef...

latest-news-card-1
Human Drugs

Draft Guide on Disseminated Valley Fever Treatments

FDA posts a draft guidance to help drugmakers design clinical trials for treatments targeting disseminated coccidioidomycosis, also known as Valley Fe...

latest-news-card-1
Human Drugs

Larimar Reports Positive Data for Nomlabofusp

Larimar Therapeutics reports encouraging long-term data from its open-label study of nomlabofusp, an investigational therapy for Friedreichs ataxia.

latest-news-card-1
Biologics

Novo Nordisk Resubmits BLA for Once-Weekly Insulin

Novo Nordisk refiles its BLA for Awiqli (insulin icodec), a once-weekly basal insulin injection for adults with Type 2 diabetes.

Biologics

FDA Tells IO Biotech to Delay Cancer Vaccine Filing

FDA tells IO Biotech not to submit a BLA for its experimental cancer vaccine Cylembio based on results from a recently completed Phase 3 trial in adva...